Rh2 was also demonstrated to inhibit the proliferation and metastasis of NSCLC cells by inducing apoptosis and suppressing epithelial-mesenchymal transition, respectively [16]. The gene discussed is RHAG; the disease is non-small cell lung carcinoma.